Dokumeds

Dokumeds is a European contract research organization (CRO) that provides a comprehensive range of clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1995 and headquartered in Riga, Latvia, the company specializes in Phase I-IV clinical development, regulatory consultancy, and pharmacovigilance across Europe and other regions. In December 2021, Dokumeds was acquired by Rho, a U.S.-based CRO, to expand its global reach and service capabilities. The company is known for its expertise in navigating complex regulatory environments in Eastern Europe and Russia. Its service portfolio includes biostatistics, data management, medical monitoring, and clinical supply logistics. Dokumeds has managed over 150 clinical studies across various therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases.